Heterocyclic compounds and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8785470
SERIAL NO

13552516

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • INFINITY PHARMACEUTICALS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Castro, Alfredo C Winchester, US 123 2523
Chan, Katrina Fremont, US 64 2869
Evans, Catherine A Somerville, US 48 1385
Janardanannair, Somarajannair Woburn, US 30 958
Lescarbeau, Andre Somerville, US 43 1306
Li, Liansheng San Diego, US 145 4945
Liu, Tao Ashland, US 555 3481
Liu, Yi San Diego, US 749 9323
Ren, Pingda San Diego, US 182 5799
Snyder, Daniel A Somerville, US 63 1280
Tremblay, Martin R Melrose, US 46 1428

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 22, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00